Erik Skullerud, a Norwegian national and resident of Switzerland, has been named chief executive of Nordic Nanovector ASA to help advance the company’s radionuclide conjugate therapies for cancer. Mr Skullerud joins the company from Element Consulting GmbH, which he co-founded, to give advice to executives in the life science sector. Prior to this, he held sales and marketing positions at both Amgen Inc and Bayer Pharma. Mr Skullerud holds a bachelor of science degree in marketing, finance and management from the Gothenburg Business School at the University of Gothenburg in Sweden.
Nordic Nanovector announced the appointment on 14 September 2021.
Copyright 2021 Evernow Publishing Ltd.